Merck & Co Inc. (MRK) News Headlines

▮ More

Date

Headline

7/18/2019 5:05:28 AM FDA Nod For MRK's Antibiotic; DRRX Awaits Big Day In Dec., Airxpanders Goes Bust

7/17/2019 7:48:20 AM Merck: FDA Approves Recarbrio - Quick Facts

7/17/2019 6:50:06 AM Merck Says FDA Approves RECARBRIO

7/9/2019 7:09:42 AM Merck Files Six SBLAs To Update Dosing Frequency For KEYTRUDA - Quick Facts

7/9/2019 6:50:50 AM Merck: FDA Accepted For Review 6 SBLAs To Update Dosing Frequency For KEYTRUDA

6/26/2019 4:13:43 AM Biotech Stocks Facing FDA Decision In July 2019

6/25/2019 7:54:01 AM Intensity Therapeutics Announces Clinical Collaboration With Merck

6/20/2019 7:35:01 AM Merck Plans Strong Growth Over Next Five Years - Quick Facts

6/20/2019 6:57:46 AM Merck Sees Strong Revenue Growth Every Year Over Next Five Years, Incl 2023

6/19/2019 3:06:39 AM AstraZeneca Receives Japanese Approval For Lung Disease Treatment

6/18/2019 7:01:32 AM Merck Reports First Approval For KEYTRUDA In Small Cell Lung Cancer

6/18/2019 6:49:42 AM Merck Says FDA Approved KEYTRUDA Anti-PD-1 Therapy In SCLC

6/18/2019 2:20:16 AM AstraZeneca: EC Oks Lynparza As Maintenance Treatment For Ovarian Cancer

6/18/2019 2:08:03 AM AstraZeneca Says EC Approves Lynparza For 1st-line Maintenance treatment Of BRCA-mutated Advanced Ovarian Cancer

6/13/2019 8:49:55 AM IBM, KPMG, Merck And Walmart Collaborate For Drug Supply Chain Blockchain Pilot

6/13/2019 8:09:05 AM IBM, KPMG, Merck And Walmart To Collaborate As Part Of FDA's Program To Evaluate Use Of Blockchain

6/13/2019 8:05:00 AM IBM, KPMG, Merck and Walmart to collaborate as part of FDA's program to evaluate the use of blockchain to protect pharmaceutical product integrity (Press Release)

6/11/2019 8:03:00 AM Merck Announces FDA Approval Of Two New Indications For KEYTRUDA - Quick Facts

6/11/2019 7:48:29 AM Merck: FDA Approves Two New Indications For KEYTRUDA

6/10/2019 7:39:48 AM Merck To Acquire Tilos Therapeutics In Up To $773 Mln Deal - Quick Facts